✦ LIBER ✦

Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC leukemia cooperative group phase II study

✍ Scribed by Willemze, R.; Jager, U.; Jehn, U.; Stryckmans, P.; Bury, J.; Suciu, S.; Solbu, G.; Zittoun, R.; Burghouts, J.; Löwenberg, B.

Book ID: 122947381
Publisher: Elsevier Science
Year: 1988
Weight: 521 KB
Volume: 24
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(88)90073-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RESULTS OF INDUCTION AND CONSOLIDATION T

RESULTS OF INDUCTION AND CONSOLIDATION TREATMENT WITH INTERMEDIATE AND HIGH-DOSE ARA-C AND m-AMSA CONTAINING REGIMENS IN PATIENTS WITH PRIMARILY FAILED OR RELAPSED ACUTE LEUKEMIA AND NON-HODGKIN'S LYMPHOMA

✍ Peters, W.G. ;Willemze, R. ;Colly, L.P. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 454 KB

Intermediate and high-dose ARA-C and m-A

Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma

✍ Willemze, R. ;Peters, W. G. ;Hennik, M. B. ;Fibbe, W. E. ;Kootte, A. M. M. ;Berk 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 314 KB

Salvage treatment for primary resistant

Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group

✍ T. De Witte; S. Suciu; D. Selleslag; B. Labar; K. Roozendaal; R. Zittoun; M. Rib 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 156 KB

A phase II trial of induction and consol

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

✍ Bouabdallah, R; Lefrère, F; Rose, C; Chaïbi, P; Harousseau, J-L; Vernant, J-P; C 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

A phase I study of tipifarnib combined w

A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over

✍ Brandwein, J M; Leber, B F; Howson-Jan, K; Schimmer, A D; Schuh, A C; Gupta, V; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Results of a multicenter phase II trial

Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib

✍ Florian Heidel; Jorge Cortes; Frank G. Rücker; Walter Aulitzky; Laurie Letvak; T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views